Development asset linked to Alkermes Pharma Ireland in public FDA and regional records.
pharma · Schizophrenia · Narcolepsy Type 1
Alkermes Pharma Ireland
Alkermes Pharma Ireland drug portfolio — 3 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Dublin, USA HQ
27 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Dublin, USA
- Employees
- 27
- Programs
- 6
- Drugs
- 3
- Patents
- 25
Alkermes Pharma Ireland pipeline
Portfolio lens on 3 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Alkermes Pharma Ireland drug portfolio — 3 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Drug portfolio
-
-
Development asset linked to Alkermes Pharma Ireland in public FDA and regional records.
-
Development asset linked to Alkermes Pharma Ireland in public FDA and regional records.